BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors

NCT00043095 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: gemcitabine hydrochloride
DRUG: ixabepilone

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]